PMID: 15229054Jul 2, 2004Paper

Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study

The American Journal of Psychiatry
Mark WeiserMichael Davidson

Abstract

The prevalence of cigarette smoking among schizophrenia patients is significantly higher than in the general population; this may reflect self-medication of symptoms and/or adverse effects of neuroleptics. The authors examined the prevalence of cigarette smoking in apparently healthy adolescents later hospitalized for schizophrenia. Each year, a random sample of male Israeli military recruits, who have been screened and found not to be suffering from major psychopathology, complete a smoking questionnaire. Through the Israeli National Psychiatric Hospitalization Case Registry, 14,248 of these adolescents were followed to determine later psychiatric hospitalization. Of the 14,248 adolescents assessed, 4,052 (28.4%) reported smoking at least one cigarette a day. Over a 4-16-year follow-up, the prevalence of schizophrenia in the entire cohort was 0.3% (N=44). Smokers were at greater risk for later schizophrenia; the adjusted relative risk was 1.94, and the 95% confidence interval (CI) was 1.05-3.58. The number of cigarettes smoked was significantly associated with the risk for schizophrenia. Compared to nonsmokers, adolescents who smoked 1-9 cigarettes/day were 1.38 times (95% CI=0.48-4.00) as likely to be hospitalized later for s...Continue Reading

Citations

Jan 9, 2008·Archives of General Psychiatry·Tyrone D CannonRobert Heinssen
Oct 7, 2008·Social Psychiatry and Psychiatric Epidemiology·Cheryl CorcoranEzra Susser
Mar 19, 2009·Social Psychiatry and Psychiatric Epidemiology·Siow Ann ChongJohn Wong
Nov 4, 2010·Social Psychiatry and Psychiatric Epidemiology·Mythily SubramaniamSiow Ann Chong
Aug 24, 2006·European Archives of Psychiatry and Clinical Neuroscience·Helge Frieling, Stefan Bleich
Sep 15, 2010·European Archives of Psychiatry and Clinical Neuroscience·Rafael SegarraMiguel Gutiérrez
Oct 20, 2012·European Archives of Psychiatry and Clinical Neuroscience·Katharina DruschWolfgang Wölwer
Mar 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jasmin M DaoFrances M Leslie
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Boris B QuednowGeorg Winterer
Jun 20, 2008·Schizophrenia Bulletin·Roman KotovJoseph E Schwartz
Apr 28, 2006·Current Opinion in Psychiatry·German F Alvarado, Naomi Breslau
Oct 26, 2006·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Scott Kellogg, Mary Jeanne Kreek
Jan 15, 2014·Cellular and Molecular Life Sciences : CMLS·Boris B QuednowMoritz J Rossner
Sep 8, 2010·Psychiatry Research·Yasuko ShinozakiEiji Yano
Dec 1, 2005·Current Psychosis & Therapeutics Reports·Emery J Fu, Kristin S Cadenhead
Sep 9, 2011·Social Psychiatry and Psychiatric Epidemiology·Nicholas MylesMatthew Large
Aug 9, 2011·Journal of Psychiatric Research·Ye-Zhi HouLisa B Dixon
Aug 12, 2009·Neuroscience and Biobehavioral Reviews·Peter DomeZoltan Rihmer
Jul 31, 2007·Schizophrenia Research·Mounir H FawziMaggie M Fawzi
Mar 27, 2007·Psychiatry Research·Karin Kristensen, Kristin S Cadenhead
Mar 10, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Iulian IancuRael D Strous
Oct 11, 2008·Journal of Psychiatric and Mental Health Nursing·C R MartinJ Atkinson
Jul 15, 2006·Addictive Behaviors·Marie-Sa GuillonPaul E Bailey
Jun 21, 2005·Neuroscience and Biobehavioral Reviews·Veena Kumari, Peggy Postma
Jun 21, 2005·Schizophrenia Research·Mark WeiserShlomo Noy
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Karin SchwartzMoshe Rehavi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here